Signaling complexes of voltage-gated calcium channels and G protein-coupled receptors

Journal of Receptors and Signal Transduction

Volumn 28, Issue 1-2, 2008, Pages 71-81

  Altier, Christophe ^a   Zamponi, Gerald W ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; DELTA OPIATE RECEPTOR; DIHYDROPYRIDINE DERIVATIVE; G PROTEIN COUPLED RECEPTOR; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NOCICEPTIN; OPIATE; VOLTAGE GATED CALCIUM CHANNEL;

CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL MEMBRANE; DRUG MECHANISM; GENE ACTIVATION; GENE ACTIVITY; GENE FUNCTION; HUMAN; NERVE CELL; PAIN; REVIEW; SPINAL GANGLION;

ANIMALS; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; CALCIUM CHANNELS, N-TYPE; HUMANS; MODELS, BIOLOGICAL; MULTIPROTEIN COMPLEXES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, OPIOID; SIGNAL TRANSDUCTION;

EID: 42549123321     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.1080/10799890801941947     Document Type: Review

References (63)

1. Schroeder JE, McCleskey EW. Inhibition of Ca2+ currents by a mu-opioid in a defined subset of rat sensory neurons. J Neurosci 1995, 13, 867-873.
2. Taddese A, Nah SY, McCleskey EW. Selective opioid inhibition of small nociceptive neurons. Science 1995, 270, 1366-1369.
3. Beedle AM, McRory JE, Poirot O, Doering CJ, Altier C, Barrere C, Hamid J, Nargeot J, Bourinet E, Zamponi GW. Agonist-independent modulation of N-type calcium channels by ORL1 receptors. Nat Neurosci 2004, 7, 118-125.
4. Altier C, Khosravani H, Evans RM, Hameed S, Peloquin JB, Vartian BA, Chen L, Beedle AM, Ferguson SS, Mezghrani A, Dubel SJ, Bourinet E, McRory JE, Zamponi GW. ORL1 receptor-mediated internalization of N-type calcium channels. Nat Neurosci 2006, 9, 31-40.
5. Tombler E, Cabanilla NJ, Carman P, Permaul N, Hall JJ, Richman RW, Lee J, Rodriguez J, Felsenfeld DP, Hennigan RF, Diverse-Pierluissi MA. G protein-induced trafficking of voltage-dependent calcium channels. J Biol Chem 2006, 281, 1827-1839.
6. Davare MA, Avdonin V, Hall DD, Peden EM, Burette A, Weinberg RJ, Horne MC, Hoshi T, Hell JW. A beta2 adrenergic receptor signaling complex assembled with the Ca2+ channel Cav1.2. Science 2001, 293, 98-101.
7. Kitano J, Nishida M, Itsukaichi Y, Minami I, Ogawa M, Hirano T, Mori Y, Nakanishi S. Direct interaction and functional coupling between metabotropic glutamate receptor subtype 1 and voltage-sensitive Cav2.1 Ca2+ channel. J Biol Chem 2003, 278, 25101-25108.
8. Wheeler DB, Randall A, Tsien RW. Roles of N-type and Q-type Ca2+ channels in supporting hippocampal synaptic transmission [see comments]. Science 1994, 264, 107-111.
9. Dunlap K, Luebke JI, Turner TJ. Exocytotic Ca2+ channels in mammalian central neurons. Trends Neurosci 1995, 18, 89-98.
10. Sutton KG, McRory JE, Guthrie H, Murphy TH, Snutch TP. P/Q-type calcium channels mediate the activity-dependent feedback of syntaxin-1A. Nature 1999, 401, 800-804.
11. Dolmetsch RE, Pajvani U, Fife K, Spotts JM, Greenberg ME. Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science 2001, 294, 333-339.
12. Khosravani H, Zamponi GW. Voltage-gated calcium channels and idiopathic generalized epilepsies. Physiol Rev 2006, 86, 941-966.
13. Mangoni ME, Traboulsie A, Leoni AL, Couette B, Marger L, Le Quang K, Kupfer E, Cohen-Solal A, Vilar J, Shin HS, Escande D, Charpentier F, Nargeot J, Lory P. Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1/alpha1G T-type calcium channels. Circ Res 2006, 98, 1422-1430.
14. Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, Lamerdin JE, Mohrenweiser HW, Bulman DE, Ferrari M, Haan J, Lindhout D, van Ommen GJ, Hofker MH, Ferrari MD, Frants RR. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996, 87, 543-552.
15. Ophoff RA, Terwindt GM, Frants RR, Ferrari MD. P/Q-type Ca2+ channel defects in migraine, ataxia and epilepsy. Trends Pharmacol Sci 1998, 19, 121-127.
16. Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, Napolitano C, Schwartz PJ, Joseph RM, Condouris K, Tager-Flusberg H, Priori SG, Sanguinetti MC, Keating MT. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004, 119, 19-31.
17. Splawski I, Yoo DS, Stotz SC, Cherry A, Clapham DE, Keating MT. CACNA1H mutations in autism spectrum disorders. J Biol Chem 2006, 281, 22085-22091.
18. Doering CJ, Zamponi GW. Molecular pharmacology of non-L-type calcium channels. Curr Pharm Des 2005, 11, 1887-1898.
19. Catterall W. Annual Review of Cell Development Biloogy 2000, 16, 521.
20. Perez-Reyes E. Molecular physiology of low-voltage-activated t-type calcium channels. Physiol Rev 2003, 83, 117-161.
21. Bichet D, Cornet V, Geib S, Carlier E, Volsen S, Hoshi T, Mori Y, De Waard M. The I-II loop of the Ca2+ channel alpha1 subunit contains an endoplasmic reticulum retention signal antagonized by the beta subunit. Neuron 2000, 25, 177-190.
22. Arikkath J, Campbell KP. Auxiliary subunits: essential components of the voltage-gated calcium channel complex. Curr Opin Neurobiol 2003, 13, 298-307.
23. Dolphin AC. Beta subunits of voltage-gated calcium channels. J Bioenerg Biomembr 2003, 35, 599-620.
24. Yasuda T, Chen L, Barr W, McRory JE, Lewis RJ, Adams DJ, Zamponi GW. Auxiliary subunit regulation of high-voltage activated calcium channels expressed in mammalian cells. Eur J Neurosci 2004, 20, 1-13.
25. Tedford HW, Zamponi GW. Direct G protein modulation of Cav2 calcium channels. Pharmacol Rev 2006, 58, 837-862.
26. Smith MT, Cabot PJ, Ross FB, Robertson AD, Lewis RJ. The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices. Pain 2002, 96, 119-127.
27. Krarup C. An update on electrophysiological studies in neuropathy. Curr Opin Neurol 2003, 16, 603-612.
28. Dunlap K, Fischbach GD. Neurotransmitters decrease the calcium component of sensory neurone action potentials. Nature 1978, 276, 837-839.
29. Ikeda SR, Schofield GG. Somatostatin blocks a calcium current in rat sympathetic ganglion neurones. J Physiol (Lond) 1989, 409, 221-240.
30. Bernheim L, Mathie A, Hille B. Characterization of muscarinic receptor subtypes inhibiting Ca2+ current and M current in rat sympathetic neurons. Proc Natl Acad Sci U S A 1992, 89, 9544-9548.
31. Mintz IM, Bean BP. GABAB receptor inhibition of P-type Ca2+ channels in central neurons. Neuron 1993, 10, 889-898.
32. Hille B. Modulation of ion-channel function by G-protein-coupled receptors. Trends Neurosci 1994, 17, 531-536.
33. Bunzow JR, Saez C, Mortrud M, Bouvier C, Williams JT, Low M, Grandy DK. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett 1994, 347, 284-288.
34. Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G, Meunier JC. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett 1994, 341, 33-38.
35. Wick MJ, Minnerath SR, Lin X, Elde R, Law PY, Loh HH. Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned mu, delta, and kappa opioid receptors. Brain Res Mol Brain Res 1994, 27, 37-44.
36. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ, Jr., Civelli O. Orphanin FQ: A neuropeptide that activates an opioidlike G protein-coupled receptor. Science 1995, 270, 792-794.
37. Knoflach F, Reinscheid RK, Civelli O, Kemp JA. Modulation of voltage-gated calcium channels by orphanin FQ in freshly dissociated hippocampal neurons. J Neurosci 1996, 16, 6657-6664.
38. Neal CR Jr, Mansour A, Reinscheid R, Nothacker HP, Civelli O, Watson SJ Jr. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J Comp Neurol 1999, 406, 503-547.
39. Larsson KP, Olsen UB, Hansen AJ. Nociceptin is a potent inhibitor of N-type Ca(2+) channels in rat sympathetic ganglion neurons. Neurosci Lett 2000, 296, 121-124.
40. Yamamoto T, Nozaki-Taguchi N, Kimura S. Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like1 receptor agonist, in the rat formalin test. Neuroscience 1997a, 81, 249-254.
41. Yamamoto T, Nozaki-Taguchi N, Kimura S. Effects of intrathecally administered nociceptin, an opioid receptor-like1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat. Neurosci Lett 1997b, 224, 107-110.
42. Gouarderes C, Tafani JA, Meunier JC, Jhamandas K, Zajac JM. Nociceptin receptors in the rat spinal cord during morphine tolerance. Brain Res 1999, 838, 85-94.
43. Ueda H, Inoue M, Takeshima H, Iwasawa Y. Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence. J Neurosci 2000, 20, 7640-7647.
44. Kisilevsky AE, Mulligan S, Altier C, Iftinca MC, Varela D, Tai C, Chen L, Hameed S, Hamid J, MacVicar BA, Zamponi GW. D1 receptors physically interact with N-type calcium channels to regulate to regulate channel distribution and dendritic calcium entry. Neuron 2008.
45. Puckerin A, Liu L, Permaul N, Carman P, Lee J, Diverse-Pierluissi MA. Arrestin is required for agonist-induced trafficking of voltage-dependent calcium channels. J Biol Chem 2006, 281, 31131-31141.
46. Huang CC, Wang SJ, Gean PW. Selective enhancement of P-type calcium currents by isoproterenol in the rat amygdala. J Neurosci 1998, 18, 2276-2282.
47. Kaneko S, Akaike A, Satoh M. Differential regulation of N- and Q-type Ca2+ channels by cyclic nucleotides and G-proteins. Life Sci 1998, 62, 1543-1547.
48. Wu L, Bauer CS, Zhen XG, Xie C, Yang J. Dual regulation of voltage-gated calcium channels by PtdIns(4,5)P2. Nature 2002, 419, 947-952.
49. Fournier F, Charnet P, Bourinet E, Vilbert C, Matifat F, Charpentier G, Navarre P, Brule G, Marlot D. Regulation by protein kinase-C of putative P-type Ca channels expressed in Xenopus oocytes from cerebellar mRNA. FEBS Lett 1993, 317, 118-124.
50. Hell JW, Westenbroek RE, Warner C, Ahlijanian MK, Prystay W, Gilbert MM, Snutch TP, Catterall WA. Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits. J Cell Biol 1993, 123, 949-962.
51. Kapur A, Yeckel MF, Gray R, Johnston D. L-Type calcium channels are required for one form of hippocampal mossy fiber LTP. J Neurophysiol 1998, 79, 2181-2190.
52. Mangoni ME, Couette B, Bourinet E, Platzer J, Reimer D, Striessnig J, Nargeot J. Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity. Proc Natl Acad Sci U S A 2003, 100, 5543-5548.
53. McDonald TF, Pelzer S, Trautwein W, Pelzer DJ. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol Rev 1994, 74, 365-507.
54. Gao T, Yatani A, Dell'Acqua ML, Sako H, Green SA, Dascal N, Scott JD, Hosey MM. cAMP-dependent regulation of cardiac L-type Ca2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits. Neuron 1997, 19, 185-196.
55. Devic E, Xiang Y, Gould D, Kobilka B. Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice. Mol Pharmacol 2001, 60, 577-583.
56. Skeberdis VA, Jurevicius J, Fischmeister R. Beta-2 adrenergic activation of L-type Ca++ current in cardiac myocytes. J Pharmacol Exp Ther 1997, 283, 452-461.
57. Zhang ZS, Cheng HJ, Ukai T, Tachibana H, Cheng CP. Enhanced cardiac L-type calcium current response to beta2-adrenergic stimulation in heart failure. J Pharmacol Exp Ther 2001, 298, 188-196.
58. Brodde OE, Michel MC. Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 1999, 51, 651-690.
59. Chen-Izu Y, Xiao RP, Izu LT, Cheng H, Kuschel M, Spurgeon H, Lakatta EG. G(i)-dependent localization of beta(2)-adrenergic receptor signaling to L-type Ca(2+) channels. Biophys J 2000, 79, 2547-2556.
60. Zhang ZS, Cheng HJ, Onishi K, Ohte N, Wannenburg T, Cheng CP. Enhanced inhibition of L-type Ca2+ current by beta3-adrenergic stimulation in failing rat heart. J Pharmacol Exp Ther 2005, 315, 1203-1211.
61. Hall DD, Davare MA, Shi M, Allen ML, Weisenhaus M, McKnight GS, Hell JW. Critical role of cAMP-dependent protein kinase anchoring to the L-type calcium channel Cav1.2 via A-kinase anchor protein 150 in neurons. Biochemistry 2007, 46, 1635-1646.
62. Oliveria SF, Dell'Acqua ML, Sather WA. AKAP79/150 anchoring of calcineurin controls neuronal L-type Ca2+ channel activity and nuclear signaling. Neuron 2007, 55, 261-275.
63. Hall DD, Feekes JA, Arachchige Don AS, Shi M, Hamid J, Chen L, Strack S, Zamponi GW, Horne MC, Hell JW. Binding of protein phosphatase 2A to the L-type calcium channel Cav1.2 next to Ser1928, its main PKA site, is critical for Ser 1928 dephosphorylation. Biochemistry 2006, 45, 3448-3459.